Literature DB >> 10321692

Occupational radiation exposure and mortality: second analysis of the National Registry for Radiation Workers.

C R Muirhead1, A A Goodill, R G Haylock, J Vokes, M P Little, D A Jackson, J A O'Hagan, J M Thomas, G M Kendall, T J Silk, D Bingham, G L Berridge.   

Abstract

The National Registry for Radiation Workers (NRRW) is the largest epidemiological study of UK radiation workers. Following the first analysis published in 1992, a second analysis has been conducted using an enlarged cohort of 124,743 workers, updated dosimetry and personal data for some workers, and a longer follow-up. Overall levels of mortality were found to be less than those expected from national rates; the standardised mortality ratio for all causes was 82, increasing to 89 after adjusting for social class. This 'healthy worker effect' was particularly strong for lung cancer and for some smoking-related non-malignant diseases. Analysis of potential radiation effects involved testing for any trend in mortality risk with external dose, after adjusting for likely confounding factors. For leukaemia, excluding chronic lymphatic leukaemia (CLL), the central estimate of excess relative risk (ERR) per Sv was similar to that estimated for the Japanese atomic bomb survivors at low doses (without the incorporation of a dose-rate correction factor); the corresponding 90% confidence limits for this trend were tighter than in the first analysis, ranging from just under four times the risk estimated at low doses from the Japanese atomic bomb survivors to about zero. For the grouping of all malignancies other than leukaemia, the central estimate of the trend in risk with dose was closer to zero than in the first analysis; also, the 90% confidence limits were tighter than before and included zero. Since results for lung cancer and non-malignant smoking-related diseases suggested the possibility of confounding by smoking, an examination was made, as in the first analysis, of all malignancies other than leukaemia and lung cancer. In this instance the central estimate of the ERR per Sv was similar to that from the A-bomb data (without the incorporation of a dose-rate correction factor), with a 90% confidence interval ranging from about four times the A-bomb value to less than zero. For multiple myeloma there was an indication of an increasing trend in risk with external dose (p = 0.06), although the evidence for this trend disappeared after omitting workers monitored for exposure to internal emitters. The second NRRW analysis provides stronger inferences than the first on occupational radiation exposure and cancer mortality; the 90% confidence intervals for the risk per unit dose are tighter than before, and now exclude values which are greater than four times those seen among the Japanese A-bomb survivors, although they are also generally consistent with an observation of no raised risk. Furthermore, there is evidence, of borderline statistical significance, of an increasing risk for leukaemia excluding CLL, and, as with solid cancers, the data are consistent with the A-bomb findings.

Entities:  

Mesh:

Year:  1999        PMID: 10321692     DOI: 10.1088/0952-4746/19/1/002

Source DB:  PubMed          Journal:  J Radiol Prot        ISSN: 0952-4746            Impact factor:   1.394


  28 in total

Review 1.  Cancer risk related to gastrointestinal diagnostic radiation exposure.

Authors:  Mimi L Chang; Jason K Hou
Journal:  Curr Gastroenterol Rep       Date:  2011-10

2.  The statistical power of epidemiological studies analyzing the relationship between exposure to ionizing radiation and cancer, with special reference to childhood leukemia and natural background radiation.

Authors:  M P Little; R Wakeford; J H Lubin; G M Kendall
Journal:  Radiat Res       Date:  2010-09       Impact factor: 2.841

3.  Incidence of haematopoietic malignancies in US radiologic technologists.

Authors:  M S Linet; D M Freedman; A K Mohan; M M Doody; E Ron; K Mabuchi; B H Alexander; A Sigurdson; M Hauptmann
Journal:  Occup Environ Med       Date:  2005-12       Impact factor: 4.402

4.  Trimming exposure data, putting radiation workers at risk: improving disclosure and consent through a national radiation dose-registry.

Authors:  Kristin Shrader-Frechette
Journal:  Am J Public Health       Date:  2007-08-29       Impact factor: 9.308

Review 5.  Estimating radiation risk from computed tomography scanning.

Authors:  Vadim Fayngersh; Michael Passero
Journal:  Lung       Date:  2009-04-07       Impact factor: 2.584

6.  Risks associated with low doses and low dose rates of ionizing radiation: why linearity may be (almost) the best we can do.

Authors:  Mark P Little; Richard Wakeford; E Janet Tawn; Simon D Bouffler; Amy Berrington de Gonzalez
Journal:  Radiology       Date:  2009-04       Impact factor: 11.105

7.  Radiation exposure from diagnostic imaging studies among patients with inflammatory bowel disease in a safety-net health-care system.

Authors:  Jason K Hou; Hoda M Malaty; Selvi Thirumurthi
Journal:  Dig Dis Sci       Date:  2013-09-12       Impact factor: 3.199

8.  Kidney cancer mortality and ionizing radiation among French and German uranium miners.

Authors:  Damien Drubay; Sophie Ancelet; Alain Acker; Michaela Kreuzer; Dominique Laurier; Estelle Rage
Journal:  Radiat Environ Biophys       Date:  2014-05-24       Impact factor: 1.925

9.  Relationship between occupational exposure to ionizing radiation and mortality at the French electricity company, period 1961-2003.

Authors:  Olivier Laurent; Camille Metz-Flamant; Agnès Rogel; Dominique Hubert; Alexandre Riedel; Yves Garcier; Dominique Laurier
Journal:  Int Arch Occup Environ Health       Date:  2010-02-11       Impact factor: 3.015

10.  Ionizing radiation and risk of chronic lymphocytic leukemia in the 15-country study of nuclear industry workers.

Authors:  Martine Vrijheid; Elisabeth Cardis; Patrick Ashmore; Anssi Auvinen; Ethel Gilbert; Rima R Habib; Hans Malker; Colin R Muirhead; David B Richardson; Agnes Rogel; Mary Schubauer-Berigan; Hélène Tardy; Maylis Telle-Lamberton
Journal:  Radiat Res       Date:  2008-11       Impact factor: 2.841

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.